November 22, 2024

MD Anderson Cancer Center

Memorial Sloan Kettering Cancer Center Now Enrolling Patients in Phase 1/2 Clinical Trial of IMUNON’s IMNN-001 in Combination with Bevacizumab in Advanced Ovarian Cancer "Ovarian Cancer Treatment Clinical Trial"
2 min read

Memorial Sloan Kettering Cancer Center Now Enrolling Patients in Phase 1/2 Clinical Trial of IMUNON’s IMNN-001 in Combination with Bevacizumab in Advanced Ovarian Cancer

 IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing non-viral DNA-mediated immunotherapy and next-generation vaccines, announces...
Read More

You may have missed

Lupin’s Humrahi Expands to Heart Health
2 min read

Lupin’s Humrahi Expands to Heart Health

November 20, 2024
Boston Scientific Launches AVVIGO™+ Multi-Modality Guidance System in India
2 min read

Boston Scientific Launches AVVIGO™+ Multi-Modality Guidance System in India

November 13, 2024
KW Delhi-6 Mall Joined Hands with Yashoda Healthcare to Spread Awareness on Breast Cancer
2 min read

KW Delhi-6 Mall Joined Hands with Yashoda Healthcare to Spread Awareness on Breast Cancer

November 7, 2024
India’s reputation as the “Pharmacy to the World” is Potentially Under Threat Substandard Imports of IPA add to the Quality Burden
3 min read

India’s reputation as the “Pharmacy to the World” is Potentially Under Threat Substandard Imports of IPA add to the Quality Burden

September 25, 2024